基于丹麦息肉病登记分析家族性腺瘤性息肉病患者中的结直肠癌
该研究利用丹麦全国性息肉病登记库,比较1990-1999年与2000-2017年家族性腺瘤性息肉病(FAP)患者的结直肠癌发病率、患病率和生存期。结果显示FAP相关结直肠癌比例显著下降,先证者结直肠癌风险显著高于筛查检出者,筛查随访使一级亲属预期寿命延长17.0年。
要点
- 2000-2017年FAP相关结直肠癌占全部结直肠癌的0.03%,较1990-1999年的0.09%显著下降(P=.001)。
- 先证者结直肠癌风险为61.6%(191例),显著高于筛查检出者的1.9%(5例)(P<.001)。
- 筛查检出者中位预期寿命72.0年,先证者为55.0年,筛查随访使一级亲属预期寿命延长17.0年。
核心结论
- 丹麦息肉病登记库能够对FAP患者进行密切监测,降低结直肠癌风险并延长生命。
研究设计与样本
- 研究基于丹麦息肉病登记库,该库为全国性完整FAP患者登记库,包含临床信息、手术操作、随访结果和病理报告。
- 研究比较了1990-1999年与2000-2017年两个时期的数据。
- 2017年登记库包含226个家系、721例FAP患者。
- 先证者定义为因肠道症状而诊断、且此前不知晓遗传性肠道疾病的患者;筛查检出者定义为在筛查中或因一级亲属诊断为FAP而发现的患者。
主要发现
- FAP平均发病率从1990-1999年的0.19/10万人/年变为2000-2017年的0.32/10万人/年(P=.91)。
- 时点患病率从1999年的4.86/10万上升至2017年底的6.11/10万(P=.005)。
- 2000-2017年期间,72,218例结直肠癌中25例与FAP相关(0.03%),较1990-1999年(30,005例中26例,0.09%)显著下降(P=.001)。
- 先证者结直肠癌风险为61.6%(191例),显著高于筛查检出者的1.9%(5例)(P<.001)。
- 筛查检出者中位预期寿命为72.0年(95%CI 63.3-80.7),先证者为55.0年(95%CI 51.2-58.8)(P<.001);筛查随访使一级亲属预期寿命延长17.0年。
临床怎么用
- 原文结论指出丹麦息肉病登记库能够对FAP患者进行密切监测,降低结直肠癌风险并延长生命。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Familial adenomatous polyposis (FAP) is an autosomal dominant disorder that increases risk for colorectal cancer (CRC). We assessed changes in the incidence and prevalence of CRC, and survival times, of patients with FAP participating in the Danish follow-up study. METHODS: We collected data from the Danish Polyposis Registry, a nationwide, complete registry of patients with FAP that includes clinical information, surgical procedures, follow-up findings, and pathology reports. We compared data between the periods of 1990-1999 and 2000-2017. In 2017, the registry contained 226 families with 721 individuals with FAP. Probands were defined as patients diagnosed based on bowel symptoms, without any knowledge of hereditary bowel disease. Call-up patients were defined as those found to have FAP during screening and due to a diagnosis of FAP in first-degree relatives. RESULTS: Although the mean incidence rate of FAP was stable from 1990-1999 (0.19/100,000/year) to 2000-2017 (0.32/100,000/year) (P = .91), the point prevalence increased from 4.86/100,000 in 1999 to 6.11/100,000 by the end of 2017 (P = .005). During 2000-2017, 25 of 72,218 CRC cases were associated with FAP (0.03%)-this was a significant decrease from 1990-1999 (26/30,005 cases; 0.09%) (P = .001). The risk of CRC was significantly higher for probands (n = 191; 61.6%) than call-up cases (n = 5; 1.9%) (P < .001). All CRCs in call-up patients were detected at the diagnosis of FAP (no cases were identified in the follow-up program). The median life expectancy for call-up patients was 72.0 years (95% CI, 63.3-80.7), compared to 55.0 years for probands (95% CI, 51.2-58.8) (P < .001). Therefore, the tracing and follow-up program increased life expectancy by 17.0 years for first-degree family members. CONCLUSION: The Danish Polyposis Registry enables close monitoring of patients with FAP, reducing risk of CRC and prolonging life.
引用
- Karstensen JG, Burisch J, Pommergaard HC, et al. Colorectal Cancer in Individuals With Familial Adenomatous Polyposis, Based on Analysis of the Danish Polyposis Registry. Clin Gastroenterol Hepatol. 2019. PMID: 30743005. doi:10.1016/j.cgh.2019.02.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。